Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Device Improves Embolic Protection

By HospiMedica staff writers
Posted on 05 Oct 2006
A new embolic protection system has been designed to better protect patients from a stroke while undergoing carotid-artery stenting procedures.

The Emboshield Pro embolic protection system (EBS) is designed to be more radiopaque than its predecessor, the Emboshield EBS, providing better visibility during x-ray angiography. More...
The device's shorter length and enhanced profile are intended to allow it to cross tighter blockages and be delivered more easily in patients with challenging carotid anatomies. The Emboshield Pro also features Barewire, a proprietary technology that allows the filter to remain stable during the normal guidewire movements that occur during device exchanges in carotid procedures. The system has received the CE Mark.

"I believe the Emboshield Pro represents a significant development in embolic protection for patients in Europe,” said Dr. Alberto Cremonesi, director of the interventional cardio-angiology unit at the Villa Maria Cecilia Hospital (Cotignola, Italy), "Its ability to be applied to many different vessel diameters and its short filter length make this device an important new option for tortuous vessels.

The Emboshield Pro is a product of Abbott Vascular (Abbott Park, IL, USA).

Approximately one-fourth of all strokes are caused by carotid artery disease, a condition wherein one or both carotid arteries in the neck become blocked by plaque, which can break off and cause stroke. This situation is exacerbated during carotid-artery stenting procedures. Embolic protection devices are designed to capture and remove particles of atherosclerotic plaque that can become dislodged during the stenting procedure, potentially leading to stroke and other complications.



Related Links:
Abbott Vascular

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.